Caregiver Reports of Neurodevelopmental Functions in Pediatric Lysosomal Storage Disorders: A Scoping Review
Journal of Inherited Metabolic Disease · 2026-05 · 49 (3)
DOI: 10.1002/jimd.70179 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 07.04.2026. Verfasst von Eileen M Gillan und 4 weiteren Autor:innen. Beteiligte Einrichtung: PhD in Rehabilitation Sciences Program, School of Health and Rehabilitation Sciences, MGH Institute of Health Professions, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Lysosomal Storage Diseases, Caregivers, Neurodevelopmental Disorders. Die Arbeit nennt 176 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Caregiver‐reported outcome measures (CROMs) complement clinical assessments of neurodevelopmental functions (NDF) in pediatric rare disease trials. This scoping review summarizes use of CROMs of NDF across bodily function, activity, and participation domains of the International Classification of Functioning, Disability, and Health (ICF) model in pediatric lysosomal storage disorders (LSDs), characterizes assessed neurodevelopmental domains, and outlines considerations for CROM selection within a comprehensive functional assessment strategy. We applied JBI methodology and adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for Scoping Reviews (PRISMA‐ScR). Primary articles reporting CROM of NDF use in children with LSDs ≤ 12 years old were identified. Study characteristics, design, and CROMs utilized were extracted. CROMs were classified as condition‐general or disease‐specific. CROM content was mapped to neurodevelopmental domains (activities of daily living [ADL], cognition, communication, physical, social–emotional function). Ninety‐eight articles published in the last 10 years reported on 38 distinct CROMs of NDF across > 20 LSDs. Nearly all studies (93%) used ≥ 1 condition‐general CROM of NDF, most commonly the Vineland Adaptive Behavioral Scales or the Pediatric Quality of Life Inventory. Eleven disease‐specific CROMs were reported, typically alongside condition‐general measures. Physical, ADL, and social–emotional domains were indexed most consistently. CROMs were endpoints in 32 LSD clinical trials. Findings illustrate the variety and common trends of CROMs of NDF used in pediatric LSD studies. This review informs selection of complementary caregiver‐reported endpoints in LSD trials based on a well‐defined, clinically meaningful construct; alignment with other endpoints and expert consensus; and operational practicality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PhD in Rehabilitation Sciences Program, School of Health and Rehabilitation Sciences, MGH Institute of Health Professions, Boston, Massachusetts, USA.
- Clinical Outcomes Consultant, Carrboro, North Carolina, USA.
- Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Eileen M Gillan, Elise L Townsend
Zitieren
APA
Gillan, E. M., Leiro, B., Nagy, A., Eichler, F., & Townsend, E. L. (2026). Caregiver Reports of Neurodevelopmental Functions in Pediatric Lysosomal Storage Disorders: A Scoping Review. Journal of Inherited Metabolic Disease, 49(3). https://doi.org/10.1002/jimd.70179
Vancouver
Gillan EM, Leiro B, Nagy A, Eichler F, Townsend EL. Caregiver Reports of Neurodevelopmental Functions in Pediatric Lysosomal Storage Disorders: A Scoping Review. Journal of Inherited Metabolic Disease. 2026;49(3). doi:10.1002/jimd.70179
BibTeX
@article{Gillan2026,
author = {Gillan, Eileen M and Leiro, Beth and Nagy, Amanda and Eichler, Florian and Townsend, Elise L},
title = {Caregiver Reports of Neurodevelopmental Functions in Pediatric Lysosomal Storage Disorders: A Scoping Review},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
volume = {49},
number = {3},
doi = {10.1002/jimd.70179}
}
EUVIMED